4 ms·
Can someone provide a compelling argument for why we should not keep charging ahead given this risk? It seems to me that drug-resistant HIV would maintain the s
by peterlk 8y ago
Can someone provide a compelling argument for why we should not keep charging ahead given this risk? It seems to me that drug-resistant HIV would maintain the status quo, but I don't really know anything about the landscape of drugs/resistance in HIV
- AllegedAlec 8y ago> I don't really know anything about the landscape of drugs/resistance in HIV HIV is a retrovirus with an absurdly high mutation rate (4 × 10−3 per base per cell, Cuevas, J. et al, 2015). In comparison: the mutation rate of influenza is about one or two orders of magnitude lower. This means that it is incredibly quick to adapt to any changes.